Structure-activity relationships for 1-alkyl-3-(l-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors:: steric and electronic effects of naphthoyl substituents.: New highly selective CB2 receptor agonists

被引:220
|
作者
Huffman, JW [1 ]
Zengin, G
Wu, MJ
Lu, JZ
Hynd, G
Bushell, K
Thompson, ALS
Bushell, S
Tartal, C
Hurst, DP
Reggio, PH
Selley, DE
Cassidy, MP
Wiley, JL
Martin, BR
机构
[1] Clemson Univ, Howard L Hunter Lab, Clemson, SC 29634 USA
[2] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
cannabinoids; structure-activity relationships; cannabinoid receptors; aminoalkylindole;
D O I
10.1016/j.bmc.2004.09.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an effort to improve indole-based CB2 cannabinoid receptor ligands and also to develop SAR for both the CB1 and CB2 receptors, 47 indole derivatives were prepared and their CB1 and CB2 receptor affinities were determined. The indole derivatives include 1-propyl- and 1-pentyl-3-(1-naphthoyl)indoles both with and without a 2-methyl substituent. Naphthoyl substituents include 4- and 7-alkyl groups as well as 2-, 4-, 6-, 7-methoxy and 4-ethoxy groups. The effects of these substituents on receptor affinities are discussed and structure-activity relationships are presented. In the course of this work three new highly selective CB2 receptor agonists were identified, 1-propyl-3-(4-methyl-1-naphthoylindole (JWH-120), 1-propyl-2-methyl-3-(6-methoxy-1-naphthoylindole (JWH-151), and 1-pentyl-3-(2-methoxy-1-naphthoylindole (JWH-267). GTPgammaS assays indicated that JWH-151 is a full agonist at CB2, while JWH-120 and JWH-267 are partial agonists. Molecular modeling and receptor docking studies were carried out on a set of 3-(4-propyl-1-naphthoyl)indoles, a set of 3-(6-methoxy-1-naphthoyl)indoles and the pair of N-pentyl-3-(2-methoxy-1-naphthoyl)indoles. Docking studies indicated that the CB1 receptor affinities of these compounds were consistent with their aromatic stacking interactions in the aromatic microdomain of the CB1 receptor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 112
页数:24
相关论文
共 50 条
  • [1] 1-alkyl-3-(1-naphthoyl)indoles as selective agonists of the CB2 cannabinoid receptor.
    Minardi, MD
    Huffman, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 167 - CHED
  • [2] 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles:: New high affinity ligands for the cannabinoid CB1 and CB2 receptors
    Huffman, John W.
    Padgett, Lea W.
    Isherwood, Matthew L.
    Wiley, Jenny L.
    Martin, Billy R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (20) : 5432 - 5435
  • [3] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [4] EXPRESSION OF CANNABINOID 1 (CB1) AND CANNABINOID 2 (CB2) RECEPTOR AND EFFECTS OF CB1/CB2 RECEPTOR AGONISTS ON DETRUSOR OVERACTIVITY ASSOCIATED WITH BLADDER OUTLET OBSTRUCTION IN RATS
    Cho, K. J.
    Kim, S. D.
    Seo, J. T.
    Kim, S. H.
    Kim, J. C.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 926 - 927
  • [5] Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
    Ashton, John C.
    Wright, Jason L.
    McPartland, John M.
    Tyndall, Joel D. A.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (14) : 1428 - 1443
  • [6] Comparison of selective agonists at cannabinoid CB1 and CB2 receptors on agonistic behaviour in mice
    Sulcova, A
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 505 - 505
  • [7] The influence of selective agonists at cannabinoid CB1 receptor and CB2 receptor on sensitization to methamphetamine behavioural effects in mice
    Landa, L
    Slais, K
    Sulcova, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S37 - S37
  • [8] Agonist selective regulation of g proteins by cannabinoid CB1 and CB2 receptors
    Glass, M
    Northup, JK
    MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1362 - 1369
  • [9] Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
    Franks, Lirit N.
    Ford, Benjamin M.
    Prather, Paul L.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [10] Resorcinol derivatives:: A novel template for the development of cannabinoid CB1/CB2 and CB2-selective agonists
    Wiley, JL
    Beletskaya, ID
    Ng, EW
    Dai, ZM
    Crocker, PJ
    Mahadevan, A
    Razdan, RK
    Martin, BR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02): : 679 - 689